Table 2 Correlation of ZC3H15 expression with clinicopathological variables in TGGA datasets.
From: ZC3H15 promotes gastric cancer progression by targeting the FBXW7/c-Myc pathway
Clinicopathological features | Cases | ZC3H15 expression | F | P | ||||
|---|---|---|---|---|---|---|---|---|
Low | % | High | % | |||||
Age | <60 | 134 | 79 | 59.0 | 55 | 41.0 | 8.009 | 0.005 |
≥60 | 278 | 119 | 42.8 | 159 | 57.2 | |||
Gender | Male | 273 | 135 | 49.5 | 138 | 50.5 | 2.042 | 0.154 |
Female | 144 | 66 | 45.8 | 78 | 54.2 | |||
H. pylori infection | Negative | 164 | 56 | 34.1 | 108 | 65.9 | 0.499 | 0.481 |
Positive | 21 | 10 | 47.6 | 11 | 52.4 | |||
Depth of invasion | T1 | 24 | 10 | 41.7 | 14 | 58.3 | 3.207 | 0.023 |
T2 | 90 | 54 | 60.0 | 36 | 40.0 | |||
T3 | 189 | 86 | 45.5 | 103 | 54.5 | |||
T4 | 111 | 51 | 46.0 | 60 | 54.0 | |||
Lymph node metastasis | N0 | 130 | 66 | 50.8 | 64 | 49.2 | 0.935 | 0.424 |
N1 | 114 | 55 | 48.2 | 59 | 51.8 | |||
N2 | 86 | 38 | 44.2 | 48 | 55.8 | |||
N3 | 77 | 39 | 50.6 | 38 | 49.4 | |||
Distant metastasis | M0 | 374 | 178 | 47.6 | 196 | 52.4 | 0.294 | 0.588 |
M1 | 22 | 14 | 63.6 | 8 | 36.4 | |||
Histologic Grade | G1 | 10 | 5 | 50.0 | 5 | 50.0 | 4.042 | 0.018 |
G2 | 153 | 61 | 39.9 | 92 | 60.1 | |||
G3 | 245 | 131 | 53.5 | 114 | 46.5 | |||
Grade | Stage I | 58 | 31 | 53.4 | 27 | 46.6 | 1.738 | 0.159 |
Stage II | 138 | 71 | 51.4 | 67 | 48.6 | |||
Stage III | 174 | 75 | 43.1 | 99 | 56.9 | |||
Stage IV | 34 | 19 | 55.9 | 15 | 44.1 | |||